Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Agilent Announces the Innovative Seahorse XF Pro Analyzer

Tuesday, January 25, 2022

Agilent Technologies Inc announced the release of the Agilent Seahorse XF Pro Analyzer featuring new pharmaoriented workflow solutions incorporating advanced experimental design and analysis tools With enhanced performance more robust and efficient w...

Prospection and Novotech Partner To Accelerate Clinical Trials With Real World Evidence

Tuesday, January 25, 2022

Global healthcare data technology company Prospection and leading AsiaPacific biotech specialist CRO Novotech Health Holdings announce a strategic partnership to combine the power of real world evidence and clinical trials to get medicines to patient...

MustGrow and Bayer sign Exclusive Agreement to Develop Sustainable Organic Biologicals in Europe, Asia Pacific, Middle East and Africa

Saturday, January 22, 2022

MustGrow Biologics Corp and Bayer have signed an Exclusive Agreement to evaluate MustGrows biological technologies to determine efficacy and commercial potential in key agricultural regions Sustainable innovations and green technologies are necessary...

​Syapse Extends Collaboration with Pfizer to Continue to Generate Real-World Evidence in Breast Cancer

Friday, January 21, 2022

Syapse a leading realworld evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing realworld care today announced that Pfizer will continue working with Syapse to advance the use of realworld data RWD from the...

Senhwa’s Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Biliary Tract Cancer

Friday, January 21, 2022

Senhwa Biosciences Inc a drug development company focusing on firstinclass therapeutics for oncology rare diseases and novel coronaviruses announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation ODD for Silmitaserti...

Seegene to Launch New COVID-19 PCR Test with a Reduced Turnaround Time Optimized for Mass Testing

Thursday, January 20, 2022

Seegene Inc South Koreas leading molecular diagnostics company announced today the upcoming launch of the Allplex SARSCoV Fast PCR Assay which can deliver PCR results in just minutes The company says that this assay is expected to reduce the total t...

Boehringer Ingelheim announces collaboration with MabGenesis to discover and develop novel monoclonal antibodies in canine

Wednesday, January 19, 2022

Boehringer Ingelheim a global leader in animal health and MabGenesis a private biopharmaceutical company headquartered in Yokohama Japan announce that they have entered into a collaboration to discover and develop novel monoclonal antibodies for pote...

Kinnate Biopharma Inc. Announces FDA Clearance of Investigational Drug Application for KIN-3248

Wednesday, January 19, 2022

Kinnate Biopharma Inc a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficulttotreat genomically defined cancers today announced that the US Food and Drug Administration FDA has cleared t...

Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate's Global Phase II Clinical Trial in Treating Parkinson's Disease

Monday, January 17, 2022

Green Valley Shanghai Pharmaceuticals Co Ltd received the letter from the US Food and Drug Administration FDA on the Investigational New Drug IND application for the global multicenter phaseII clinical trial of Oligomannate marketed as GV the company...

BigHat Biosciences Completes First Stage of Research Collaboration with Amgen

Wednesday, January 12, 2022

BigHat Biosciences Inc a biotechnology company with an artificial intelligencemachine learningguided antibody discovery and development platform today announced the successful completion of the first stage of a previously undisclosed research collabo...